Waddell & Reed Financial’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | $72.6M | Sell |
1,613,947
-536,823
| -25% | -$24.1M | 0.15% | 178 |
|
2020
Q4 | $122M | Hold |
2,150,770
| – | – | 0.26% | 109 |
|
2020
Q3 | $102M | Sell |
2,150,770
-15,555
| -0.7% | -$738K | 0.24% | 113 |
|
2020
Q2 | $128M | Buy |
2,166,325
+14
| +0% | +$825 | 0.33% | 81 |
|
2020
Q1 | $102M | Sell |
2,166,311
-23,826
| -1% | -$1.13M | 0.33% | 83 |
|
2019
Q4 | $132M | Sell |
2,190,137
-989,941
| -31% | -$59.8M | 0.33% | 83 |
|
2019
Q3 | $191M | Buy |
3,180,078
+19
| +0% | +$1.14K | 0.49% | 48 |
|
2019
Q2 | $204M | Sell |
3,180,059
-182,247
| -5% | -$11.7M | 0.51% | 43 |
|
2019
Q1 | $273M | Sell |
3,362,306
-135,756
| -4% | -$11M | 0.68% | 33 |
|
2018
Q4 | $189M | Sell |
3,498,062
-334,649
| -9% | -$18.1M | 0.54% | 43 |
|
2018
Q3 | $198M | Sell |
3,832,711
-697,389
| -15% | -$36M | 0.44% | 56 |
|
2018
Q2 | $189M | Hold |
4,530,100
| – | – | 0.44% | 56 |
|
2018
Q1 | $200M | Hold |
4,530,100
| – | – | 0.45% | 57 |
|
2017
Q4 | $228M | Sell |
4,530,100
-12,000
| -0.3% | -$604K | 0.51% | 49 |
|
2017
Q3 | $230M | Sell |
4,542,100
-598,100
| -12% | -$30.3M | 0.51% | 52 |
|
2017
Q2 | $261M | Sell |
5,140,200
-10,400
| -0.2% | -$529K | 0.58% | 44 |
|
2017
Q1 | $207M | Sell |
5,150,600
-592,200
| -10% | -$23.8M | 0.44% | 66 |
|
2016
Q4 | $275M | Sell |
5,742,800
-70,600
| -1% | -$3.38M | 0.6% | 45 |
|
2016
Q3 | $213M | Sell |
5,813,400
-135,800
| -2% | -$4.98M | 0.44% | 63 |
|
2016
Q2 | $139M | Buy |
5,949,200
+148,100
| +3% | +$3.45M | 0.29% | 94 |
|
2016
Q1 | $235M | Buy |
5,801,100
+30,800
| +0.5% | +$1.25M | 0.44% | 65 |
|
2015
Q4 | $357M | Hold |
5,770,300
| – | – | 0.58% | 51 |
|
2015
Q3 | $233M | Buy |
5,770,300
+1,000
| +0% | +$40.4K | 0.38% | 71 |
|
2015
Q2 | $332M | Buy |
5,769,300
+318,900
| +6% | +$18.4M | 0.47% | 66 |
|
2015
Q1 | $347M | Hold |
5,450,400
| – | – | 0.48% | 62 |
|
2014
Q4 | $337M | Sell |
5,450,400
-43,700
| -0.8% | -$2.7M | 0.47% | 65 |
|
2014
Q3 | $213M | Buy |
5,494,100
+130,300
| +2% | +$5.06M | 0.3% | 90 |
|
2014
Q2 | $185M | Buy |
5,363,800
+48,900
| +0.9% | +$1.68M | 0.27% | 98 |
|
2014
Q1 | $230M | Buy |
5,314,900
+574,300
| +12% | +$24.8M | 0.35% | 77 |
|
2013
Q4 | $189M | Buy |
4,740,600
+506,200
| +12% | +$20.2M | 0.3% | 90 |
|
2013
Q3 | $159M | Buy |
4,234,400
+357,100
| +9% | +$13.4M | 0.3% | 89 |
|
2013
Q2 | $104M | Buy |
+3,877,300
| New | +$104M | 0.22% | 113 |
|